Multicentre Trial of Staphylococcus Susceptibility to Antibiotics in Moscow and St. Petersburg

Antibiotiki i Khimioterapiya

Volumn 43, Issue 7, 1998, Pages 15-25

  Sidorenko, S V ^a   Rezvan, S P ^a   Grudinina, S A ^a   Krotova, L A ^a   Sterkhova, G V ^a  

^a National Research Centre of Antibiotics   (Russian Federation)

Author keywords

Antibiotic susceptibility; MRS; Staphylococci

Indexed keywords

OXACILLIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTICENTER STUDY; PENICILLIN RESISTANCE; RUSSIAN FEDERATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

AMPICILLIN RESISTANCE; BETA-LACTAM RESISTANCE; CROSS INFECTION; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MOSCOW; OXACILLIN; PENICILLINS; RUSSIA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 2542641103     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National Committee for Clinical Standards Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A3/5th ed NCCLS, PA 1993.
2. Neumeister B., Kastner S., Conrad S et al Characterization of coagulase-negative staphylococci causing nosocomial infections in preterm infants. Eur J Clin Microbiol Infect Dis 1995; 14: 10: 856-863.
3. Skov R., Gotrschau A., Skinhoj P. et al Sraphylococcus aureus bacteremia: A 14-year nationwide study in hemotological patients with malignant disease or agranulocytosis. Scand J Infect Dis 1995; 27: 6: 563-568
4. Bush K, Jacoby G.A., Medeiros A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 39 8: 1211-1233.
5. Hamilton-Miller J.M., Ramsay J. Stability of cephaloridine and cephalothin to staphylococcal penicillinase. J Gen Microbiol 1967; 49: 491-501.
6. Zygmunt D.J., Stratton C.W., Kernodle D.S. Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother 1992, 36. 440-445
7. Lacvey R. W. Antibiotic resistance in Staphylococcus aureus and streptococci Br Med Bull 1984; 40: 77-83.
8. Leclerq R , Courvalin P. Bacterial resistance to macrolide, lineosamide and streptogramin antibiotics by target modification. Antimicrob Agent Chemother 1991; 35: 1267-1272
9. Courvalin P. Transfer of antibiotic resistance genes between grampositive and gramnegative bacteria. Ibid 1994, 38: 1447-1451
10. Weisblum B. Inducible resistance to macrolides, lincosamides and streptogramin B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression. A review. J Antimicrob Chemother 1985; 16: Suppl A. 63-69
11. Ounissi H., Derlot E , Carlier C, Courvalin P. Gene homogeneity for aminoglycoside-modifying enzymes in grampositive cocci Antimicrob Agents Chemother 1990; 34: 2164-2168.
12. Courvalin P. Interpretative reading of antimicrobial susceptibility tests. ASM News 1992; 58: 7: 368-375.
13. Thornsberry C. Susceptibility of clinical bacterial isolates to ciprofloxacin in the United States 1992. Tennessee 1992; 27.
14. Barber M. Methicillin-resistant staphylococci. Clin Pathol 1961; 14: 385-393
15. Jevons M P. "Celbelin"-resistant staphylococci. Br Med J 1961; 1: 124-125.
16. Hartman B.M., Tomasz A. Low-affinity penicillin binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol 1984; 158: 513-516
17. Beck W., Berger-Bachi B , Kayzer F.H Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mecspecific DNA. Ibid 1986; 165: 373-378.
18. Hanaki H., Akagi H., Masaru Y et al. TOC-39, a novel parenteral broad spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 1995; 39: 5: 1120-1126.
19. Tomasz A., Nachman S., Leaf H Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Ibid 1991; 35: 124-129.
20. Acar J R , Courvalin P. Chabert Y.A Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins. Ibid 1970; 10: 280-285.
21. Klimek J. J , Marsik F.J., Bartlet R.C. et al. Clinical, epidemiologic, and bacteriologic observations of an outbreak of methicillin-resistant Stapylococcus aureus in large community hospital. Am J Med 1076; 61: 340-345
22. Antibiorgam Committee of the French Society for Microbiology. Statement Pathol Biol 1994; 42 8: I-VIII
23. Working party of the British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27 Suppl D
24. Voss A., Doebbeling B.N. The worldwide prevalence of methicillinresistant Staphylococcus aureus. Intern J Anttmicrob Agents 1995; 5: 2: 101 -106.
25. Moreno F., Crisp C., Jorgensen J H., Patterxon J.E. Methicillin-resistant Staphylococcus aureus as a community organism. Clinical Infectious Diseases 1995; 21: 5: 1308-1312.
26. Scheel O., Lyon D.J, Rosdahl V. T. et al. In vitro susceptibility of isolates of methicillin resistant Staphylococcus aureus in 1988-1993. J Antimicrob Chemother 1996; 37: 2: 243-251.
27. Cercenado E., Garcialeoni M.E., Diaz M.D. et al. Emergence of teicoplanin-resistant coagulase negative staphylococci. J Clin Microbiol 1996, 34: 7: 1765-1768
28. Mainardi J.L., Shlaes D.M., Goering R V et al Decreased teicoplanin susceptibility of methicillin resistant strains of Strains of Staphylococcus aureus. J lnf Dis 1995; 171: 6: 1646-1650.
29. Johnston J., Honea N., Van de Weghe M. et al. Emerging vancomycin resistance in staphylococci detected by MicroScan. Dried overnight panels. 36th ICAAC. New Orleans, Louisiana 1996; Abstr LB14.
30. Swartz MN. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci USA 1994; 91: 2420-2427.